Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 520,000 | 458,000 | 565,000 | 261,000 |
| General And Administrative Expense | 520,000 | 458,000 | 565,000 | 261,000 |
| Other Operating Expenses | 167,000 | 89,000 | 3,000 | 12,000 |
| Operating Expense | 687,000 | 547,000 | 568,000 | 273,000 |
| Operating Income | -687,000 | -547,000 | -568,000 | -273,000 |
| EBIT | -444,000 | -1.0M | -854,000 | -902,000 |
| Interest Expense | 1,000 | 2,000 | 2,000 | 28,000 |
| Interest Expense Non Operating | 1,000 | 2,000 | 2,000 | 28,000 |
| Net Interest Income | -1,000 | -2,000 | -2,000 | -28,000 |
| Other Income Expense | 243,000 | -467,000 | -286,000 | -629,000 |
| Other Non Operating Income Expenses | 31,000 | 32,000 | 68,000 | 216,000 |
| Special Income Charges | -25,000 | 0.00 | 103,000 | 0.00 |
| Write Off | 25,000 | 0.00 | -- | -- |
| Gain On Sale Of Security | 237,000 | -499,000 | -457,000 | -845,000 |
| Pretax Income | -445,000 | -1.0M | -856,000 | -930,000 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Income From Continuing Operation Net Minority Interest | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Income Including Noncontrolling Interests | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Income Common Stockholders | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Income | -445,000 | -1.0M | -856,000 | -930,000 |
| EBITDA | -444,000 | -1.0M | -854,000 | -902,000 |
| Normalized EBITDA | -656,000 | -515,000 | -500,000 | -57,000 |
| Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 |
| Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 |
| Basic Average Shares | 50.9M | 50.9M | 50.0M | 43.5M |
| Diluted Average Shares | 50.9M | 50.9M | 50.0M | 43.5M |
| Total Unusual Items | 212,000 | -499,000 | -354,000 | -845,000 |
| Total Unusual Items Excluding Goodwill | 212,000 | -499,000 | -354,000 | -845,000 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -657,000 | -517,000 | -502,000 | -85,000 |
| Diluted NI Availto Com Stockholders | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Income Continuous Operations | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Non Operating Interest Income Expense | -1,000 | -2,000 | -2,000 | -28,000 |
| Other Gand A | 431,000 | 302,000 | 306,000 | 212,000 |
| Other Special Charges | -- | -- | -103,000 | -- |
| Salaries And Wages | 89,000 | 156,000 | 259,000 | 49,000 |
| Total Expenses | 687,000 | 547,000 | 568,000 | 273,000 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 788,000 | 1.3M | 1.1M | 84,000 |
| Cash Cash Equivalents And Short Term Investments | 1.4M | 1.8M | 2.0M | 84,000 |
| Cash Financial | 788,000 | 1.3M | 1.1M | 84,000 |
| Other Short Term Investments | 636,000 | 465,000 | 890,000 | -- |
| Accounts Receivable | 19,000 | 36,000 | 43,000 | 27,000 |
| Receivables | 19,000 | 36,000 | 43,000 | 27,000 |
| Prepaid Assets | -- | -- | -- | 25,200 |
| Current Assets | 1.4M | 1.8M | 2.1M | 111,000 |
| Net PPE | 5.6M | 5.3M | 6.0M | 5.8M |
| Investments And Advances | -- | -- | 890,000 | 1.3M |
| Other Non Current Assets | 350,000 | 322,000 | 237,000 | 224,000 |
| Total Non Current Assets | 6.0M | 5.7M | 6.3M | 7.3M |
| Total Assets | 7.4M | 7.5M | 8.3M | 7.4M |
| Current Debt | -- | 51,000 | 127,000 | 700,000 |
| Current Debt And Capital Lease Obligation | -- | 51,000 | 127,000 | 700,000 |
| Accounts Payable | 37,000 | 51,000 | -- | -- |
| Payables | 37,000 | 51,000 | -- | -- |
| Payables And Accrued Expenses | 62,000 | 51,000 | 127,000 | 565,000 |
| Current Accrued Expenses | 25,000 | 0.00 | -- | -- |
| Current Liabilities | 62,000 | 51,000 | 127,000 | 1.3M |
| Total Non Current Liabilities Net Minority Interest | 337,000 | 310,000 | 225,000 | 1.2M |
| Total Liabilities Net Minority Interest | 399,000 | 361,000 | 352,000 | 2.5M |
| Common Stock | 13.5M | 13.3M | 13.3M | 9.6M |
| Capital Stock | 13.5M | 13.3M | 13.3M | 9.6M |
| Additional Paid In Capital | 41.5M | 41.5M | 41.5M | 41.5M |
| Retained Earnings | -50.4M | -49.9M | -49.0M | -48.1M |
| Gains Losses Not Affecting Retained Earnings | -- | -- | 65,000 | 65,000 |
| Other Equity Adjustments | -- | -- | 65,000 | 65,000 |
| Common Stock Equity | 7.0M | 7.1M | 8.0M | 4.9M |
| Stockholders Equity | 7.0M | 7.1M | 8.0M | 4.9M |
| Total Equity Gross Minority Interest | 7.0M | 7.1M | 8.0M | 4.9M |
| Total Capitalization | 7.0M | 7.1M | 8.0M | 4.9M |
| Net Tangible Assets | 7.0M | 7.1M | 8.0M | 4.9M |
| Tangible Book Value | 7.0M | 7.1M | 8.0M | 4.9M |
| Working Capital | 1.4M | 1.8M | 2.0M | -1.2M |
| Invested Capital | 7.0M | 7.1M | 8.1M | 5.6M |
| Total Debt | -- | 51,000 | 127,000 | 700,000 |
| Net Debt | -- | -- | -- | 616,000 |
| Share Issued | 51.3M | 50.9M | 50.8M | 43.5M |
| Ordinary Shares Number | 51.3M | 50.9M | 50.8M | 43.5M |
| Current Notes Payable | -- | 51,000 | 127,000 | 700,000 |
| Dueto Related Parties Non Current | -- | -- | 0.00 | 1.0M |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | -- | -- | 890,000 | 1.3M |
| Investmentin Financial Assets | -- | -- | 890,000 | 1.3M |
| Long Term Provisions | 337,000 | 310,000 | 225,000 | 211,000 |
| Other Equity Interest | 2.3M | 2.3M | 2.2M | 1.9M |
| Tradeand Other Payables Non Current | -- | -- | 0.00 | 0.00 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -521,000 | -504,000 | -437,000 | -62,000 |
| Cash Flow From Continuing Operating Activities | -521,000 | -504,000 | -437,000 | -62,000 |
| Stock Based Compensation | 89,000 | 156,000 | 259,000 | 49,000 |
| Change In Working Capital | 28,000 | -69,000 | -120,000 | 189,000 |
| Changes In Account Receivables | -- | 7,000 | -16,000 | -22,000 |
| Change In Receivables | 17,000 | 7,000 | -16,000 | -22,000 |
| Change In Payables And Accrued Expense | 11,000 | -76,000 | -104,000 | 211,000 |
| Change In Payable | -- | -76,000 | -104,000 | 211,000 |
| Other Non Cash Items | -- | -- | -67,000 | -215,000 |
| Capital Expenditure | -- | -- | -564,000 | -281,000 |
| Purchase Of PPE | -- | -- | -564,000 | -306,000 |
| Net PPE Purchase And Sale | 0.00 | 1.2M | 377,000 | -281,000 |
| Purchase Of Investment | -206,000 | 0.00 | -- | -- |
| Sale Of Investment | 227,000 | 0.00 | -- | -- |
| Net Investment Purchase And Sale | 21,000 | 0.00 | -- | -- |
| Investing Cash Flow | -244,000 | 675,000 | -187,000 | -244,000 |
| Cash Flow From Continuing Investing Activities | -244,000 | 675,000 | -187,000 | -244,000 |
| Issuance Of Capital Stock | -- | 0.00 | 1.5M | 0.00 |
| Net Common Stock Issuance | -- | 0.00 | 1.5M | 0.00 |
| Financing Cash Flow | 225,000 | 12,000 | 1.7M | 0.00 |
| Cash Flow From Continuing Financing Activities | 225,000 | 12,000 | 1.7M | 0.00 |
| Effect Of Exchange Rate Changes | -- | -- | -7,000 | 5,000 |
| Changes In Cash | -540,000 | 183,000 | 1.1M | -306,000 |
| Beginning Cash Position | 1.3M | 1.1M | 84,000 | 385,000 |
| End Cash Position | 788,000 | 1.3M | 1.1M | 84,000 |
| Free Cash Flow | -521,000 | -504,000 | -437,000 | -343,000 |
| Asset Impairment Charge | 25,000 | 0.00 | -- | -- |
| Capital Expenditure Reported | -- | -- | -- | -305,700 |
| Change In Account Payable | -- | -76,000 | -438,000 | 211,000 |
| Change In Prepaid Assets | -- | -- | -- | -22,500 |
| Common Stock Issuance | -- | 0.00 | 1.5M | 0.00 |
| Gain Loss On Investment Securities | -46,000 | -- | -- | -- |
| Net Foreign Currency Exchange Gain Loss | -1,000 | 0.00 | 7,000 | -6,000 |
| Net Income From Continuing Operations | -445,000 | -1.0M | -856,000 | -930,000 |
| Net Other Financing Charges | -- | -- | -40,000 | -- |
| Net Other Investing Changes | -265,000 | -506,000 | -564,000 | 37,000 |
| Operating Gains Losses | -47,000 | -- | -103,000 | -6,000 |
| Proceeds From Stock Option Exercised | 225,000 | 12,000 | 225,000 | 0.00 |
| Sale Of PPE | 0.00 | 1.2M | 377,000 | -281,000 |
| Unrealized Gain Loss On Investment Securities | -171,000 | 425,000 | 450,000 | 851,000 |